[1]
E. Lattuada, M. Lanzafame, C. Grosso, and F. Soldani, et al., “Optimal fosamprenavir regimen to prevent lipid abnormalities”, Acta Biomed, vol. 80, no. 3, pp. 200–202, Dec. 2009, Accessed: Apr. 22, 2026. [Online]. Available: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/1171